Article: New Self-Administration Device For Imitrex(R) Injection; Now Available By Proscription In The United States

 
  STATdose(TM) System Offers Easy-To-Use Delivery System in 
   Size of a Cassette Tape 

Imitrex(R) (sumatriptan succinate) STATdose(TM) System, a compact, easy-to-use injector unit for self-administration of Imitrex Injection, a breakthrough therapy for the acute treatment of migraine, is now available to consumers in the United States by prescription.

The device marks the next step in the continuing efforts of Glaxo Wellcome Inc. to advance therapy for many of the 23 million people in the United States who suffer from migraine, an often debilitating, biological disease that occurs in periodic attacks, with each attack ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!